Alimera Sciences reported $1.81M in Cost of Sales for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
Abbvie ABBV:US $ 4499M 307M
Aerie Pharmaceuticals AERI:US $ 6.18M 0.52M
Alimera Sciences ALIM:US $ 1.81M 0.25M
Bayer BAYN:GR € 4546M 152M
Insmed INSM:US $ 10.84M 993K
Novartis NOVN:VX SF 3754M 79M
Regeneron Pharmaceuticals REGN:US $ 693.7M 385.7M